GB005 INC has a total of 18 patent applications. It decreased the IP activity by 57.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Canada and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SHANGHAI ALLIST PHARMACEUTICAL, DYBLY AG and FARINA CARLO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 4 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Laurent Alain | 16 |
#2 | Morris Stephen J | 14 |
#3 | Rose Yannick | 7 |
#4 | Morris Stephen | 2 |
#5 | Alain Laurent | 1 |
#6 | Jaquith James | 1 |
#7 | Stephen J Morris | 1 |
#8 | Coburn Craig Alan | 1 |
#9 | Lopez Luis Antonio | 1 |
#10 | Kumar Dange Vijay | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021011428A1 | Heterocyclic kinase inhibitors |